Literature DB >> 24738042

Statistical Analysis of Repeated MicroRNA High-Throughput Data with Application to Human Heart Failure: A Review of Methodology.

Shesh N Rai1, Herman E Ray2, Xiaobin Yuan1, Jianmin Pan1, Tariq Hamid3, Sumanth D Prabhu3.   

Abstract

Complex experimental designs present unique challenges in the analysis of microRNA (miRNA) Cycle to Threshold (Ct) values. In this manuscript, we discuss various statistical techniques and their application in an analysis performed at the JG Brown Cancer Center. We consider data quality evaluation, data normalization, and statistical hypothesis procedures all in context of the example. The experiment utilized as the motivating example involved repeated sampling over time. The intra-subject correlation created by the repeated sampling should be incorporated into the analysis resulting in additional significant miRNAs. The statistical techniques leveraged to analyze miRNA Ct values resulting from qPCR should incorporate key features of the experimental design. It discusses potential issues with the commonly used methodologies when the experiment collects multiple samples from the same individuals over time.

Entities:  

Keywords:  hypothesis testing; miRNA; normalization; repeated measurements

Year:  2012        PMID: 24738042      PMCID: PMC3984897          DOI: 10.2147/OAMS.S27907

Source DB:  PubMed          Journal:  Open Access Med Stat        ISSN: 2230-3251


  17 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  A comparison of normalization methods for high density oligonucleotide array data based on variance and bias.

Authors:  B M Bolstad; R A Irizarry; M Astrand; T P Speed
Journal:  Bioinformatics       Date:  2003-01-22       Impact factor: 6.937

3.  Estimating the occurrence of false positives and false negatives in microarray studies by approximating and partitioning the empirical distribution of p-values.

Authors:  Stan Pounds; Stephan W Morris
Journal:  Bioinformatics       Date:  2003-07-01       Impact factor: 6.937

4.  Analyzing real-time PCR data by the comparative C(T) method.

Authors:  Thomas D Schmittgen; Kenneth J Livak
Journal:  Nat Protoc       Date:  2008       Impact factor: 13.491

5.  Impact of normalization on miRNA microarray expression profiling.

Authors:  Sylvain Pradervand; Johann Weber; Jérôme Thomas; Manuel Bueno; Pratyaksha Wirapati; Karine Lefort; G Paolo Dotto; Keith Harshman
Journal:  RNA       Date:  2009-01-28       Impact factor: 4.942

6.  Models for longitudinal data: a generalized estimating equation approach.

Authors:  S L Zeger; K Y Liang; P S Albert
Journal:  Biometrics       Date:  1988-12       Impact factor: 2.571

Review 7.  Genetic variation in microRNA networks: the implications for cancer research.

Authors:  Bríd M Ryan; Ana I Robles; Curtis C Harris
Journal:  Nat Rev Cancer       Date:  2010-06       Impact factor: 60.716

8.  Neuronal microRNA deregulation in response to Alzheimer's disease amyloid-beta.

Authors:  Nicole Schonrock; Yazi D Ke; David Humphreys; Matthias Staufenbiel; Lars M Ittner; Thomas Preiss; Jürgen Götz
Journal:  PLoS One       Date:  2010-06-11       Impact factor: 3.240

Review 9.  Toward microRNA-based therapeutics for heart disease: the sense in antisense.

Authors:  Eva van Rooij; William S Marshall; Eric N Olson
Journal:  Circ Res       Date:  2008-10-24       Impact factor: 17.367

10.  Measuring microRNAs: comparisons of microarray and quantitative PCR measurements, and of different total RNA prep methods.

Authors:  Robert A Ach; Hui Wang; Bo Curry
Journal:  BMC Biotechnol       Date:  2008-09-11       Impact factor: 2.563

View more
  8 in total

1.  miRNA Signature of Hepatocellular Carcinoma Vascularization: How the Controls Can Influence the Signature.

Authors:  Silvia Fittipaldi; Francesco Vasuri; Sonia Bonora; Alessio Degiovanni; Giacomo Santandrea; Alessandro Cucchetti; Laura Gramantieri; Luigi Bolondi; Antonia D'Errico
Journal:  Dig Dis Sci       Date:  2017-06-21       Impact factor: 3.199

2.  Urine stabilization and normalization strategies favor unbiased analysis of urinary EV content.

Authors:  Riccardo Vago; Giorgia Radano; Davide Zocco; Natasa Zarovni
Journal:  Sci Rep       Date:  2022-10-21       Impact factor: 4.996

Review 3.  Data Normalization Strategies for MicroRNA Quantification.

Authors:  Heidi Schwarzenbach; Andreia Machado da Silva; George Calin; Klaus Pantel
Journal:  Clin Chem       Date:  2015-09-25       Impact factor: 8.327

4.  Different histological types of active intraplaque calcification underlie alternative miRNA-mRNA axes in carotid atherosclerotic disease.

Authors:  Francesco Vasuri; Carmen Ciavarella; Silvia Fittipaldi; Rodolfo Pini; Andrea Vacirca; Mauro Gargiulo; Gianluca Faggioli; Gianandrea Pasquinelli
Journal:  Virchows Arch       Date:  2019-09-10       Impact factor: 4.064

5.  Assay reproducibility in clinical studies of plasma miRNA.

Authors:  Jonathan Rice; Henry Roberts; James Burton; Jianmin Pan; Vanessa States; Shesh N Rai; Susan Galandiuk
Journal:  PLoS One       Date:  2015-04-08       Impact factor: 3.240

6.  Tissue miRNA 483-3p expression predicts tumor recurrence after surgical resection in histologically advanced hepatocellular carcinomas.

Authors:  Francesco Vasuri; Silvia Fittipaldi; Vanessa De Pace; Laura Gramantieri; Valentina Bertuzzo; Matteo Cescon; Antonio D Pinna; Michelangelo Fiorentino; Antonia D'Errico; Matteo Ravaioli
Journal:  Oncotarget       Date:  2018-04-03

7.  Statistical Issues and Group Classification in Plasma MicroRNA Studies With Data Application.

Authors:  Shesh N Rai; Chen Qian; Jianmin Pan; Marion McClain; Maurice R Eichenberger; Craig J McClain; Susan Galandiuk
Journal:  Evol Bioinform Online       Date:  2020-04-14       Impact factor: 1.625

8.  miR-16-5p Is a Stably-Expressed Housekeeping MicroRNA in Breast Cancer Tissues from Primary Tumors and from Metastatic Sites.

Authors:  Gabriel Rinnerthaler; Hubert Hackl; Simon Peter Gampenrieder; Frank Hamacher; Clemens Hufnagl; Cornelia Hauser-Kronberger; Franz Zehentmayr; Gerd Fastner; Felix Sedlmayer; Brigitte Mlineritsch; Richard Greil
Journal:  Int J Mol Sci       Date:  2016-01-26       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.